Description
CagriSema Blend 5MG/5MG – Co-Formulated Cagrilintide + Semaglutide (Single Vial) CagriSema Blend is a single-vial co-formulation combining 5 mg cagrilintide (a long-acting amylin receptor agonist) and 5 mg semaglutide (a GLP-1 receptor agonist) in one 10 mg lyophilized powder.
Reference specifications
- Pairs an amylin analog with a GLP-1 agonist
- Studied for metabolic and appetite research
- Investigated for body-weight endpoints in research models
- Concentration




